Correlations between PAI-1 and MPO values and study parameters
| PAI-1 (ng/mL) | MPO (ng/mL) | |
| Waist (cm) | r 0.520, p<0.001 | r 0.346, p=0.005 |
| TG (mg/dL) | r 0.548, p<0.001 | r 0.229, p=0.053 |
| HDL-C (mg/dL) | r −0.290, p=0.014 | r −0.252, p=0.033 |
| LDL-C (mg/dL) | r 0.374, p=0.001 | r 0.132, p=0.268 |
| ApoB (mg/dL) | r 0.439, p<0.001 | r 0.177, p=0.136 |
| Glucose (mg/dL) | r 0.435, p<0.001 | r 0.079, p=0.508 |
| Insulin (µU/mL) | r 0.460, p<0.001 | r 0.370, p=0.002 |
| HOMA index | r 0.506, p<0.001 | r 0.352, p=0.003 |
| IMT (mm) | r 0.412, p=0.003 | r −0.069, p=0.632 |
Bold indicates statistically significant (p<0.05).
ApoB, apolipoprotein B; FCH, familial combined hyperlipidemia; HDL-C, high density lipoprotein cholesterol; HOMA, homeostasis model assessment; IMT, intima media thickness; LDL-C, low density lipoprotein cholesterol; MPO, myeloperoxidase; PAI-1, plasminogen activator inhibitor type-1; TC, total cholesterol; TG, triglycerides; waist, abdominal circumference.